Fully Diluted Share CountWhat is the expected fully diluted share count (incl all options, warrants, MeddCan and Mettrum acquisitions). My guess is when the dust settles by end of 2017 CGC will be at 200 million. We all need to use a higher share count in our valuations. Also what sort sort forward looking price earnings ratio or EBIDA multiple would be realistic. I think we could safely use 20x forward earnings, especially in the first couple years starting with 2018 forecasts. Once we have that kinda in focus then we can talk abut market share by market segment (Med, Rec) domestic and international. I think even with 200 million shares we can conservatively value CGC at $35-50/share by 2018 Q2.